Literature DB >> 9226718

Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.

G Russo1, A Gast, E J Schlaeger, A Angiolillo, C Pietropaolo.   

Abstract

A human prothrombin cDNA has been engineered to obtain a cDNA coding for a secreted form of human prethrombin-2. The secreted prethrombin-2 has been produced in a mammalian expression system using DXB11 cells, a mutant strain of CHO cells in which the dihydrofolate reductase gene has been deleted, and an expression vector carrying the dihydrofolate reductase cDNA. Methotrexate-induced gene amplification favored an efficient production of the recombinant protein which accumulated in the culture medium of the DXB11 cells. Growth in suspension of the stable transformants in an airlift fermenter resulted in the production of 25 mg/L recombinant prethrombin-2. The recombinant protein was purified using single-step affinity chromatography on a recombinant-hirudin column and activated by agarose gel-immobilized ecarin. All purified recombinant prethrombin-2 was activated and the generated recombinant thrombin showed catalytic properties identical to those of plasma-derived alpha-thrombin. This expression system can be used to prepare mutants of prethrombin-2 for structure-function studies investigating thrombin interactions with substrate proteins, inhibitors, and cell membranes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226718     DOI: 10.1006/prep.1997.0733

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

1.  Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors.

Authors:  H J Böhm; D W Banner; L Weber
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.